Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 18 open reading frame 32 (C18orf32) encodes a small 76-amino-acid protein localized primarily to the endoplasmic reticulum and lipid droplets in a wide range of human tissues[4][10][11][5]. It is implicated in the positive regulation of the canonical NF-kappa-B signaling pathway and may be involved in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors, which are important for membrane protein anchoring[1][5][3]. The gene is associated with rare congenital disorders linked to GPI anchor biosynthesis defects[3]. However, the specific molecular function remains poorly characterized, and it is not currently considered a validated or canonical therapeutic target such as a receptor, enzyme, transporter, or transcription factor[3][5][11]. Its role may be supportive or regulatory rather than being a direct target for drugs. Its alternative names reflect its protein family classification and its suspected—yet unconfirmed—role in NF-kappa-B pathway activation[3][1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 18 open reading frame 32 (C18orf32).